Atacand Candesartan

Atacand is a pharmaceutical product containing the active ingredient candesartan, an angiotensin II receptor blocker (ARB) primarily used to treat high blood pressure and heart failure. The brand was developed by Takeda Pharmaceutical Company, a Japanese multinational pharmaceutical company. Candesartan was patented in 1990 and approved for medical use in 1997. The product is manufactured in multiple countries to meet global demand. Takeda Pharmaceutical Company remains the ultimate owner of the Atacand brand, with its headquarters in Japan. There are no known subsidiaries that own the brand locally.